Prime Medicine, Inc.

Historical 13F Holders

Symbol
PRME
CUSIP
74168J101
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 74168J101 since 12/18/2024, largest first.

Filer % of Class Filed
GV 2019, L.P. 13G/A
12.3% 11/12/2025
Event 9/30/2025
ARCH Venture Fund XII, L.P. 13D/A
8.4% 11/13/2026
Event 11/12/2026
ARK Investment Management LLC 13G
5.5% 11/13/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Newpath Partners, L.P. 13G/A
4.7% 2/14/2025
Event 12/31/2024
FMR LLC 13G/A
3.8% 11/5/2025
Event 9/30/2025
T. Rowe Price Investment Management, Inc. 13G/A 3.3% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 188 123 M $377M
2026 Q2 188 107 M $393M
2026 Q1 194 98.6 M $343M
2025 Q4 186 98.1 M $340M
2025 Q3 168 92.4 M $512M
2025 Q2 123 58.7 M $145M
2025 Q1 128 60.4 M $120M
2024 Q4 134 64.3 M $188M
2024 Q3 118 68.7 M $266M
2024 Q2 124 68.9 M $354M
2024 Q1 116 66.7 M $467M
2023 Q4 107 48.7 M $431M
2023 Q3 84 49.5 M $472M
2023 Q2 80 46.1 M $676M
2023 Q1 77 41.7 M $512M
2022 Q4 68 41.3 M $768M